Chronic Myeloid Leukemia: How to Treat During Pregnancy |
0.25 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
CRS and ICANS Management in CAR T/Bispecific Antibody Therapies |
0.75 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
Debate: Is the Addition of Polatuzumab Vedotin the New Standard First-Line Therapy for Diffuse Large B-Cell Lymphoma? |
0.75 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
Dental Care for Patients with Cancer: What Oncologists Need to Know |
1.00 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
Diagnosis and Management of Blastic Plasmacytoid Dendritic Cell Neoplasm |
0.50 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
Diffuse Large B-Cell Lymphoma: Sequencing Therapy for Relapsed/Refractory Disease |
0.50 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
Effective and Safe Telehealth Delivery and Remote Patient Monitoring |
1.00 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
Evaluation and Treatment of Primary Central Nervous System Lymphoma |
0.50 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
Expanding the Reach of Clinical Trials |
0.75 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
Expansion of Recommendations for Hereditary Cancers |
1.00 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
Expert Perspectives on Updates and Advances in Individualizing CLL/SLL Therapy Across the Disease Course |
1.50 |
06/30/2025 - 12:00am to 12/30/2025 - 11:59pm |
Expert Perspectives on Updates and Advances in Individualizing CLL/SLL Therapy Across the Disease Course |
1.50 |
05/29/2025 - 9:00pm to 07/01/2025 - 12:00am |
Financial Toxicity of Cancer Care |
0.75 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
From Theory to Practice: Building Sustainable, High-Impact Patient Navigation Models |
1.00 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
Hereditary Cancer Syndromes: MSK CATCH Program (Comprehensive Assessment, Treatment, and Prevention of Cancers with Hereditary Dispositions) |
0.75 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |